ER also interacts with epidermal growth factor receptors (EGFRs), and the combination of EGFR tyrosine kinase inhibitors and ER antagonists gives maximal inhibition of tumor cell proliferation in vitro and also anti-tumor activity in mouse tumor xenograft models in vivo (14, 15). The gene discussed is EGFR; the disease is neoplasm.